Switzerland currently reports an research & development by business enterprise, pharmaceutical industry in constant ppp $ of 5,042.70 million, which represents an increase of 467.84 million (10.2%) from 2020.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in Switzerland
No matching regions
Similar regions to Switzerland
Business R&D pharmaceutical in constant PPP $
More indicators for Switzerland
Government R&D in security as % of government support
0.57%
+0.16%
(2021)
Higher-education-finacing R&D financed by general university in local currency
45,166.20M
+1,982.46M
(2021)
R&D financed by rest of the world in local currency
13,491.13M
-451.15M
(2021)
Government R&D financed by rest of the world in local currency
37.06M
+1.86M
(2022)
Business R&D financed by rest of the world in local currency
10,446.47M
-500.14M
(2021)
Non-profit R&D growth rate
1.79%
-4.45%
(2021)
Switzerland Business R&D pharmaceutical in constant PPP $ between 1996 and 2021
| Period | Business R&D pharmaceutical in constant PPP $ | Change |
|---|---|---|
| 2021 | 5,042.70M | +467.84M |
| 2020 | 4,574.86M | +383.93M |
| 2019 | 4,190.93M | +91.47M |
| 2018 | 4,099.46M | +43.17M |
| 2017 | 4,056.29M | +315.71M |
| 2016 | 3,740.58M | +394.55M |
| 2015 | 3,346.03M | +281.19M |
| 2014 | 3,064.84M | +103.03M |
| 2013 | 2,961.81M | -50.98M |
| 2012 | 3,012.78M | -165.51M |
| 2011 | 3,178.30M | -210.81M |
| 2010 | 3,389.11M | -199.58M |
| 2009 | 3,588.69M | -111.50M |
| 2008 | 3,700.19M | +0.39M |
| 2007 | 3,699.80M | +102.55M |
| 2006 | 3,597.25M | +216.98M |
| 2005 | 3,380.27M | +327.77M |
| 2004 | 3,052.50M | +377.52M |
| 2003 | 2,674.98M | +363.01M |
| 2002 | 2,311.97M | +382.62M |
| 2001 | 1,929.35M | +324.50M |
| 2000 | 1,604.85M | +273.57M |
| 1999 | 1,331.28M | +251.27M |
| 1998 | 1,080.01M | +224.29M |
| 1997 | 855.72M | +210.76M |
| 1996 | 644.96M |